What are the risk factors for hungry bone syndrome?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 27, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Risk Factors for Hungry Bone Syndrome

Hungry bone syndrome should be suspected in patients with major skeletal complications (particularly brown tumors/osteitis fibrosa cystica) or severe preoperative vitamin D deficiency undergoing parathyroid surgery. 1

Primary Risk Factors

Skeletal Disease Markers

The most critical predictors of hungry bone syndrome are markers of high bone turnover and severe skeletal disease:

  • Elevated alkaline phosphatase (ALP): ALP >302 IU/L demonstrates 78.3% sensitivity and 98.9% specificity for HBS 2. This is consistently identified as an independent predictor across multiple studies 3, 4, 5
  • Osteitis fibrosa cystica/brown tumors: Presence of these lesions increases HBS risk 7.7-fold (OR 7.7,95% CI 1.5-40.6) 2 and represents the most severe form of skeletal involvement 1
  • Low bone mineral density: Low T-scores are independent predictors, reflecting chronic skeletal calcium deficit 3, 6

Biochemical Parameters

Preoperative markers:

  • Markedly elevated PTH: iPTH >121 pmol/L increases HBS risk 100-fold (OR 100.5,95% CI 4.6-2225.8) 2. Higher PTH levels consistently predict HBS across primary and secondary hyperparathyroidism 3, 4, 5
  • Severe vitamin D deficiency: Low 25-OH vitamin D levels predispose to HBS 1, 2
  • Elevated preoperative calcium: Higher baseline calcium correlates with HBS risk 3
  • Low preoperative phosphate: Hypophosphatemia indicates high bone turnover 3
  • Elevated Ca/P ratio: Reflects dysregulated mineral metabolism 3

Postoperative marker:

  • Day 1 calcium <8.6 mg/dL (2.15 mmol/L): This cutoff demonstrates strong predictive accuracy for subsequent HBS development 3

Patient and Surgical Factors

  • Younger age: Younger patients have higher bone turnover capacity and greater risk 4, 2
  • Lower body weight/BMI: Leaner patients show increased HBS susceptibility 2
  • Type of hyperparathyroidism: Secondary hyperparathyroidism (SHPT) carries higher risk (72.2% incidence) compared to tertiary hyperparathyroidism 4
  • Surgical extent:
    • Total parathyroidectomy with autotransplantation shows 100% HBS incidence in some series 4
    • Concomitant thyroid surgery increases risk 3
    • Heavier total weight of resected parathyroid glands predicts HBS 5
  • Multi-glandular or revision surgery: These procedures carry higher HBS risk 1

Emerging Risk Factors

Recent evidence highlights HBS-like states can occur after:

  • Anti-resorptive therapy: Particularly denosumab in patients with extensive osteolytic lesions 7, 8
  • Potent calcimimetics: Rapid suppression of bone resorption can precipitate severe hypocalcemia 7

Clinical Context

The pathophysiology involves abrupt cessation of PTH-driven bone resorption while bone formation continues unabated, creating an intense skeletal mineral sink. The high-turnover bone state (particularly in osteitis fibrosa cystica) creates expansive unmineralized osteoid that avidly mineralizes post-surgery 6.

Key Diagnostic Features

HBS presents with severe hypocalcemia (<2.1 mmol/L or 8.4 mg/dL) lasting >4 days, accompanied by:

  • Normal or elevated PTH (distinguishing it from hypoparathyroidism) 1
  • Hypophosphatemia
  • Hypomagnesemia
  • Low urinary calcium despite supplementation 1

Critical Pitfall

Do not confuse HBS with postoperative hypoparathyroidism. The distinction is made by measuring PTH, phosphate, magnesium, and urinary calcium 1. In HBS, PTH remains normal or elevated (>10 pg/mL at day 1), whereas hypoparathyroidism shows suppressed PTH.

References

Related Questions

What is the definition of hungry bone syndrome?
What physical examination signs indicate hypocalcemia?
What is the recommended treatment for acute muscle twitching caused by hypocalcemia?
Can a drotaverine injection be used to treat a 7‑year‑old boy presenting with acute abdominal pain?
In a 5‑year‑old child with a prior history of renal calculi, do tiny echogenic foci seen in the renal sinus on ultrasound indicate that they are not stones?
What is the recommended insulin dosing regimen for children with diabetic ketoacidosis?
What is the recommended management of serotonin syndrome?
What is the preferred surgical correction for an adult with stable astigmatism, a clear cornea, central corneal thickness ≥500 µm, and no active ocular surface disease?
A patient taking fluvoxamine 100 mg twice daily reports occasional limb twitching; what is the appropriate management?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.